[Drug-induced reaction patterns of regional cerebral blood flow (author's transl)].
D000284:Administration, Oral; D001549:Benzamides / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000098:blood supply; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003911:Dextrans / Q000627:therapeutic use; D003936:Diagnosis, Computer-Assisted; D004809:Ephedrine / Q000627:therapeutic use; D005029:Ethylenediamines / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D007511:Ischemia / Q000188:drug therapy; D007556:Isoxsuprine / Q000627:therapeutic use; D009756:Nylidrin / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D011868:Radioisotopes; D012044:Regression Analysis; D012588:Scintillation Counting; D013013:Sorbose / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use; D014978:Xenon
D001549:Benzamides; D001565:Benzoates; D003911:Dextrans; D005029:Ethylenediamines; D011868:Radioisotopes; D013566:Sympathomimetics; D014665:Vasodilator Agents; D014970:Xanthines; D014978:Xenon; D009756:Nylidrin; D013806:Theophylline; D010208:Papaverine; D004809:Ephedrine; D013013:Sorbose; D007556:Isoxsuprine
Medikamentös veruraschte Reaktionsmuster der regionalen Hirndurchblutung.